New CXCR4 antagonist peptide R (Pep R) improves standard therapy in colorectal cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'New CXCR4 antagonist peptide R (Pep R) improves standard therapy in colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences